Abstract

Polymorphisms of the vitamin D receptor gene (VDR) have been associated inconsistently with various diseases, across populations of diverse origin. The T(f) allele of the functional SNP FokI, in exon 2 of VDR, results in a longer vitamin D receptor protein (VDR) isoform, proposed to be less active. Genetic association of VDR with disease is likely confounded by ethnicity and environmental factors such as plasma 25(OH)D3 status. We hypothesized that VDR expression, VDR level and transactivation of target genes, CAMP and CYP24A1, depend on vitamin D, ethnicity and FokI genotype. Healthy volunteers participated in the study (African, n = 40 and White, n = 20). Plasma 25(OH)D3 levels were quantified by LC-MS and monocytes cultured, with or without 1,25(OH)2D3. Gene expression and protein level was quantified using qRT-PCR and flow cytometry, respectively. Mean plasma 25(OH)D3 status was normal and not significantly different between ethnicities. Neither 25(OH)D3 status nor 1,25(OH)2D3 supplementation significantly influenced expression or level of VDR. Africans had significantly higher mean VDR protein levels (P<0.050), nonetheless transactivated less CAMP expression than Whites. Genotyping the FokI polymorphism by pyrosequencing together with HapMap data, showed a significantly higher (P<0.050) frequency of the CC genotype in Africans than in Whites. FokI genotype, however, did not influence VDR expression or VDR level, but influenced overall transactivation of CAMP and 1,25(OH)2D3-elicited CYP24A1 induction; the latter, interacting with ethnicity. In conclusion, differential VDR expression relates to ethnicity, rather than 25(OH)D3 status and FokI genotype. Instead, VDR transactivation of CAMP is influenced by FokI genotype and, together with ethnicity, influence 1,25(OH)2D3-elicited CYP24A1 expression. Thus, the expression and role of VDR to transactivate target genes is determined not only by genetics, but also by ethnicity and environment involving complex interactions which may confound disease association.

Highlights

  • The vitamin D receptor (VDR) is a ligand-activated transcription factor that mediates the genomic actions of vitamin D

  • Results support that differential VDR expression relates to ethnicity, rather than 25(OH)D3 status and FokI genotype

  • VDR transactivation of cathelicidin antimicrobial protein (CAMP) is influenced by FokI genotype which, together with ethnicity, influences 1,25(OH)2D3-elicited CYP24A1 expression

Read more

Summary

Introduction

The vitamin D receptor (VDR) is a ligand-activated transcription factor that mediates the genomic actions of vitamin D. These actions involve regulation of calcium homeostasis, cell growth and differentiation, detoxification of xenobiotics, and modulation of adaptive and innate immunity; the latter including activation of monocyte-macrophages [1,2]. 1,25(OH)2D3-bound VDR facilitates heterodimerization with the retinoid X receptor (RXR) and binding to vitamin D response elements (VDREs), essential for transcription of VDR-regulated genes. 1,25(OH)2D3 availability determines VDR-mediated transactivation of target genes. The genes coding for 1,25(OH)2D3-catabolizing cytochrome P450 enzyme (CYP24A1) and the human cathelicidin antimicrobial protein (CAMP) are examples of 1,25(OH)2D3-regulated target genes. CAMP contains at least one identified VDRE in its promoter region [8], and is induced by 1,25(OH)2D3 supplementation in primary keratinocytes, monocytes, and neutrophils [9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call